LONG [eLong,] SC 13D/A: (Original Filing)
[SCHEDULE 13D CUSIP No. 290138205 1 NAMES OF REPORTING PERSONS. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) o (a) o (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS (SEE INSTRUCTIONS)]
LONG [eLong,] SC 13D/A: SCHEDULE 13D CUSIP No. 290138205 1 NAMES OF
[SCHEDULE 13D CUSIP No. 290138205 1 NAMES OF REPORTING PERSONS. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) o (a) o (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS (SEE INSTRUCTIONS)]
CPHI [CHINA PHARMAS,] CORRESP: (Original Filing)
[June 24, 2009 Attn: Mr. Jim B. Rosenberg Re: China Pharma Holdings, Inc. Form 10-K for the Fiscal Year Ended December 31, 2008 Filed March 17, 2009 Form 10-KSB/A for the Fiscal Year Ended December 31, 2007 Forms 10-Q/A for the Quarterly Periods Ended March 31 and June 30, and September 30, 2008 Filed March 12, 2009 File No. 000-29523]
CPHI [CHINA PHARMAS,] CORRESP: June 24, 2009 Attn: Mr. Jim B. Rosenberg
[June 24, 2009 Attn: Mr. Jim B. Rosenberg Re: China Pharma Holdings, Inc. Form 10-K for the Fiscal Year Ended December 31, 2008 Filed March 17, 2009 Form 10-KSB/A for the Fiscal Year Ended December 31, 2007 Forms 10-Q/A for the Quarterly Periods Ended March 31 and June 30, and September 30, 2008 Filed March 12, 2009 File No. 000-29523]
CPHI [CHINA PHARMAS,] 10-Q/A: (Original Filing)
[EXPLANATORY NOTE Except as set forth below, this Form 10-Q/A does not modify, amend or update in any way any other items or disclosure in the Form 10-Q. This Form 10-Q/A continues to speak as of the date of the original Form 10-Q and other than as specifically reflected in the Form 10-Q/A does not reflect events occurring after the] [Certification of Chief Executive Officer I, Zhilin Li, certify that: 2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by] [Financial Certification of Chief Officer I, Frank Waung, certify that: 2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER 18 U.S.C. SECTION 1350, Zhilin Li Chief Executive Officer EX-32.1 4 cph10qaex321033109.htm] [CERTIFICATION OF CHIEF FINANCIAL OFFICER 18 U.S.C. SECTION 1350, Frank Waung Chief Financial Officer EX-32.2 5 cph10qaex322033109.htm]
CPHI [CHINA PHARMAS,] 10-Q/A: EXPLANATORY NOTE Except as set forth below, this
[EXPLANATORY NOTE Except as set forth below, this Form 10-Q/A does not modify, amend or update in any way any other items or disclosure in the Form 10-Q. This Form 10-Q/A continues to speak as of the date of the original Form 10-Q and other than as specifically reflected in the Form 10-Q/A does not reflect events occurring after the] [Certification of Chief Executive Officer I, Zhilin Li, certify that: 2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by] [Financial Certification of Chief Officer I, Frank Waung, certify that: 2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER 18 U.S.C. SECTION 1350, Zhilin Li Chief Executive Officer EX-32.1 4 cph10qaex321033109.htm] [CERTIFICATION OF CHIEF FINANCIAL OFFICER 18 U.S.C. SECTION 1350, Frank Waung Chief Financial Officer EX-32.2 5 cph10qaex322033109.htm]
CPHI [CHINA PHARMAS,] 10-K/A: (Original Filing)
[o x o x x o x Large accelerated filer o Accelerated filer o Non-accelerated filer o] [January 11, 2008 1) A retainer of RMB 40,000 per year, payable quarterly within 5 days of the start of the quarter. If you agree to the terms and conditions stated above, please sign and date this letter below. Chairman of the Board EX-10.7 2 cph10kaex107123108.htm] [January 11, 2008 1) A retainer of RMB 40,000 per year, payable quarterly within 5 days of the start of the quarter. If you agree to the terms and conditions stated above, please sign and date this letter below. Chairman of the Board EX-10.8 3 cph10kaex108123108.htm] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with] [CERTIFICATION OF CHIEF FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Frank Waung, certify that: 2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER 18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Zhilin Li Chief Executive Officer EX-32.1 6 cph10kaex321123108.htm] [CERTIFICATION OF CHIEF FINANCIAL OFFICER 18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Frank Waung Chief Financial Officer EX-32.2 7 cph10kaex322123108.htm]
CPHI [CHINA PHARMAS,] 10-K/A: o x o x x o x Large
[o x o x x o x Large accelerated filer o Accelerated filer o Non-accelerated filer o] [January 11, 2008 1) A retainer of RMB 40,000 per year, payable quarterly within 5 days of the start of the quarter. If you agree to the terms and conditions stated above, please sign and date this letter below. Chairman of the Board EX-10.7 2 cph10kaex107123108.htm] [January 11, 2008 1) A retainer of RMB 40,000 per year, payable quarterly within 5 days of the start of the quarter. If you agree to the terms and conditions stated above, please sign and date this letter below. Chairman of the Board EX-10.8 3 cph10kaex108123108.htm] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with] [CERTIFICATION OF CHIEF FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Frank Waung, certify that: 2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER 18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Zhilin Li Chief Executive Officer EX-32.1 6 cph10kaex321123108.htm] [CERTIFICATION OF CHIEF FINANCIAL OFFICER 18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Frank Waung Chief Financial Officer EX-32.2 7 cph10kaex322123108.htm]
CPHI [CHINA PHARMAS,] 10-Q/A: (Original Filing)
[EXPLANATORY NOTE Except set forthbelow, this Form 10-Q/A does not modify, amend or update in any way any other items or disclosure in the Form 10-Q. This Form 10-Q/Antinues toeak of thete of the original Form 10-Q and other thanecifically reflected in the Form 10-Q/A does not reflect events occurring after the filing of the] [Certification of Chief Executive Officer I, Zhilin Li, certify that: 2)Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the] [Financial Certification of Chief Officer I, Frank Waung, certify that: 2)Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER 18 U.S.C. SECTION 1350, Zhilin Li Chief Executive Officer cph10qaex321033109.htm 4 EX-32.1] [CERTIFICATION OF CHIEF FINANCIAL OFFICER 18 U.S.C. SECTION 1350, Frank Waung ChiefFinancial Officer cph10qaex322033109.htm 5 EX-32.2]
CPHI [CHINA PHARMAS,] 10-Q/A: EXPLANATORY NOTE Except set forthbelow, this Form 10-Q/A
[EXPLANATORY NOTE Except set forthbelow, this Form 10-Q/A does not modify, amend or update in any way any other items or disclosure in the Form 10-Q. This Form 10-Q/Antinues toeak of thete of the original Form 10-Q and other thanecifically reflected in the Form 10-Q/A does not reflect events occurring after the filing of the] [Certification of Chief Executive Officer I, Zhilin Li, certify that: 2)Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the] [Financial Certification of Chief Officer I, Frank Waung, certify that: 2)Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER 18 U.S.C. SECTION 1350, Zhilin Li Chief Executive Officer cph10qaex321033109.htm 4 EX-32.1] [CERTIFICATION OF CHIEF FINANCIAL OFFICER 18 U.S.C. SECTION 1350, Frank Waung ChiefFinancial Officer cph10qaex322033109.htm 5 EX-32.2]
